Mianserin Hydrochloride API Manufacturers | Suppliers | Exporters

Mianserin Hydrochloride

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

3 API Suppliers, 1 USDMF, 1 CEP/COS, 1 JDMF, 2 Listed Suppliers, $ API Reference Price

FINISHED DOSAGE FORMULATIONS

26 FDF Dossiers, 19 Europe, 2 Australia, 5 South Africa

DIGITAL CONTENT

1 NEWS #PharmaBuzz

1 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

14 Finished Drug Prices

14 Finished Drug Prices

MARKET PLACE

1 FDF Dossiers

1 FDF Dossiers

REF. STANDARDS & IMPURITIES

4 EDQM

4 EDQM

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ Xls

Filters

FILTER :

filter Company Name Reset all filters

2 All

01 1LEBSA

02 1Fareva

filter Product Name Reset all filters

filter Country Reset all filters

01

LEBSA

Spain

2024 ACI Convention

Not Confirmed

LEBSA- Your strategic API source for niche molecules.

Contact Supplier

Spain

Virtual Booth

Digital Content

Mianserin Hydrochloride

About the Company : Lebsa is an innovative European laboratory that specializes in the synthesis, manufacture and commercialization of APIs with a focus on niche products. With a track record spanning...

Lebsa is an innovative European laboratory that specializes in the synthesis, manufacture and commercialization of APIs with a focus on niche products. With a track record spanning 70 years, Lebsa has established itself as a reputable player in the global pharmaceutical market, particularly in generic API manufacturing. Headquartered in Barcelona, Spain, Lebsa exports up to 90% of its production. Lebsa's state-of-the-art facilities, located near Barcelona, feature cutting-edge technology, equipment and automated processes. Lebsa has expertise in registering APIs in countries across Europe, Canada, Taiwan, China, Russia, Brazil and Japan.

02

Fareva

Luxembourg

BOS Manchester

Attending

Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

Contact Supplier

Luxembourg

Virtual Booth

Digital Content

Mianserin Hydrochloride

About the Company : Fareva’s API division has special technologies for high potent APIs (HPAPIs) down to the OEB-6 level, aseptic crystallization (sterile APIs), Spray Drying etc, with volumes rangi...

Fareva’s API division has special technologies for high potent APIs (HPAPIs) down to the OEB-6 level, aseptic crystallization (sterile APIs), Spray Drying etc, with volumes ranging from a few kgs to multi tons production. Fareva’s Drug Product division offers different technologies: injectables (lyophilized, solution, suspension, vial, ampoules, pre-filled syringes), unidoses and multidoses BFS, solids (tablets, hard capsules, powders), semi-solids (cream, gel suppositories) and liquids (oral and external, sprays, aerosols).